Johnson & Johnson (NYSE: JNJ) has reported E.P.S. of $1.93 for its second fiscal quarter (ending June 30) versus $2.07 for the same period a year ago — a decline of -7%. This performance was $-0.76 short of the consensus estimate of $2.69. For the latest four quarters through June 30, E.P.S. were $6.69 versus $4.76 for the same period a year ago — an increase of 41%.
Recent Price Action
Johnson & Johnson (NYSE: JNJ) stock enjoyed a large increase of 3.7% on 7/17/24. The stock closed at $156.58. Moreover, trading volume in this advance was unusually high at 196% of normal. The stock has been weak relative to the market over the last nine months but has risen 6.5% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be above the cost of capital, JNJ is expected to continue to be a major Value Builder.
Johnson & Johnson has a current Value Trend Rating of F (Lowest Rating). This rating combines consistent signals from two proprietary PTR measures of a stock’s attractiveness. Johnson & Johnson has a slightly negative Power Rating of 32 and a poor Appreciation Score of 26, with the Lowest Value Trend Rating the result.
Rating Review
In light of this new information we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment